eCite Digital Repository
Effects of vitamin D supplementation on disabling foot pain in patients with symptomatic knee osteoarthritis
Citation
Tu, L and Zheng, S and Cicuttini, F and Jin, X and Han, W and Zhu, Z and Antony, B and Winzenberg, T and Jones, G and Gu, J and Wluka, AE and Ding, C, Effects of vitamin D supplementation on disabling foot pain in patients with symptomatic knee osteoarthritis, Arthritis Care & Research, (July) pp. 1-26. ISSN 2151-464X (2020) [Refereed Article]
 | PDF (Accepted article) Available from 06 December 2021 742Kb |
Copyright Statement
This is the peer reviewed version of the following article, which has been published in final form at http://dx.doi.org/10.1002/acr.24371. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Abstract
Methods: A post hoc study was conducted from a randomized double-blind placebo-controlled trial named the VItamin D Effect on Osteoarthritis (VIDEO) study. Symptomatic knee OA patients with serum 25-hydroxyvitamin D levels between 12.5 nmol/L to 60 nmol/L were included and randomly allocated to either monthly vitamin D3 or placebo treatment (1:1) for 2 years. Manchester Foot Pain and Disability Index (MFPDI) was used to evaluate foot pain and Disabling foot pain was defined as at least one of the 10 functional limitation items (items 1-9,11) being documented as on 'most/every day(s)' in the last month. A repeated-measure mixed effect model was used to analyze the change of MFPDI scores between groups adjusting for potential confounders.
Results: A total of 413 patients with a mean age of 63.2 years (49.7% males) were enrolled and 340 completed the study. The mean MFPDI score was 22.8±7.3, with 23.7% participants having disabling foot pain at baseline. There were significant differences in MFPDI scores change between groups over 2 years, with more improvements in vitamin D group than in placebo group (-0.03 vs. 1.30, P=0.013) and more improvement in those maintaining sufficient vitamin D levels (n=226) than those who did not (n=114) (-0.09 vs. 2.19, P=0.001).
Conclusion: Vitamin D supplementation and maintenance of sufficient vitamin D levels may improve foot pain in those with knee OA.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | osteoarthritis, foot pain, vitamin D |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Clinical sciences |
| Research Field: | Rheumatology and arthritis |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Zheng, S (Miss Shuang Zheng) |
| UTAS Author: | Jin, X (Mr Xingzhong Jin) |
| UTAS Author: | Han, W (Dr Weiyu Han) |
| UTAS Author: | Zhu, Z (Mr Zhaohua Zhu) |
| UTAS Author: | Antony, B (Dr Benny Eathakkattu Antony) |
| UTAS Author: | Winzenberg, T (Professor Tania Winzenberg) |
| UTAS Author: | Jones, G (Professor Graeme Jones) |
| UTAS Author: | Ding, C (Professor Chang-Hai Ding) |
| ID Code: | 141722 |
| Year Published: | 2020 |
| Deposited By: | Menzies Institute for Medical Research |
| Deposited On: | 2020-11-12 |
| Last Modified: | 2020-12-07 |
| Downloads: | 0 |
Repository Staff Only: item control page